Benaroya Research Institute's third annual immunology symposium, "New Horizons in Immunity and Disease," will take place on Tuesday, May 5, 2026. Due to strong interest and enthusiastic support from the immunology community, we’re relocating this year’s event to Bell Harbor International Conference Center in Seattle, a larger venue that will better accommodate our growing audience.
We’re excited to once again bring together leading voices from the local and national immunology research community for a day of collaboration, discovery, discussion and connection. Building on two years of full houses, dynamic presentations, and meaningful dialogue, this year’s symposium is set to continue that momentum.
Mark your calendars and save the date: more details, including program highlights and event speakers, will be shared soon.
Please contact BRI's marketing and communications team via email with any questions.
Keynote Speaker
The 2026 BRI Immunology Symposium welcomes our keynote speaker, Jay Shendure, MD, PhD, Lead Scientific Director, Seattle Hub for Synthetic Biology; Scientific Director, Brotman Baty Institute; Professor, Department of Genome Sciences, University of Washington; Investigator, Howard Hughes Medical Institute.
BRI Immunology Symposium Speakers
Previous speakers at the BRI Immunology Symposium have included:
News
InnovationRx: Microsoft Cofounder Paul Allen’s Estate Launches $500 Million Fund for Research
Learn More ➡
New Fund for Science and Technology Announces Inaugural Grants
Learn More ➡
Paul Allen’s Estate Launches Science and Tech Fund With $3.1 Billion Endowment
Learn More ➡
Featured Publications
cytoKernel: robust kernel embeddings for assessing differential expression of single-cell data
Bioinformatics
Single-cell transcriptomic profiling of eosinophils and airway immune cells in childhood asthma
J Allergy Clin Immunol
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study
Front Med (Lausanne)
Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study
Diabetes Care
Cockroach immunotherapy modulates dominant T cell responses independent of allergen extract content
J Allergy Clin Immunol
